These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11580862)

  • 1. Development of Dengue virus type 2 replicons capable of prolonged expression in host cells.
    Pang X; Zhang M; Dayton AI
    BMC Microbiol; 2001; 1():18. PubMed ID: 11580862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIV.
    Pang X; Zhang M; Dayton AI
    BMC Microbiol; 2001; 1():28. PubMed ID: 11747468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and Application of Flavivirus Replicons.
    Kümmerer BM
    Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.
    Lai CY; Hu HP; King CC; Wang WK
    J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02).
    Mosimann AL; de Borba L; Bordignon J; Mason PW; dos Santos CN
    J Virol Methods; 2010 Jan; 163(1):147-52. PubMed ID: 19761796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication.
    Leardkamolkarn V; Sirigulpanit W; Chotiwan N; Kumkate S; Huang CY
    Virus Res; 2012 Feb; 163(2):552-62. PubMed ID: 22197424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of Genomic and Sub-Genomic Dengue Infectious Replicons.
    Cao TM; Kuhn RJ
    Methods Mol Biol; 2022; 2409():77-96. PubMed ID: 34709637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
    Aberle JH; Aberle SW; Kofler RM; Mandl CW
    J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication.
    Alvarez DE; De Lella Ezcurra AL; Fucito S; Gamarnik AV
    Virology; 2005 Sep; 339(2):200-12. PubMed ID: 16002117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of molecular strategies to develop a live dengue vaccine.
    Lai CJ; Bray M; Men R; Cahour A; Chen W; Kawano H; Tadano M; Hiramatsu K; Tokimatsu I; Pletnev A; Arakai S; Shameem G; Rinaudo M
    Clin Diagn Virol; 1998 Jul; 10(2-3):173-9. PubMed ID: 9741643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
    Kato F; Hishiki T
    Viruses; 2016 May; 8(5):. PubMed ID: 27164125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon.
    Lee TC; Lin YL; Liao JT; Su CM; Lin CC; Lin WP; Liao CL
    Biochem Biophys Res Commun; 2010 Jun; 396(3):596-601. PubMed ID: 20412785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.
    Mady BJ; Kurane I; Erbe DV; Fanger MW; Ennis FA
    J Gen Virol; 1993 May; 74 ( Pt 5)():839-44. PubMed ID: 8492089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication.
    Naik NG; Wu HN
    J Virol; 2015 Jul; 89(13):6746-60. PubMed ID: 25878113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
    Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.
    Shan C; Xie X; Zou J; Züst R; Zhang B; Ambrose R; Mackenzie J; Fink K; Shi PY
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and application of dengue virus reverse genetic systems.
    Davidson AD
    Methods Mol Biol; 2014; 1138():113-30. PubMed ID: 24696334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.